Third, based on the function of CYP2E1, further analysis of the state of xenobiotics in the GDM and control groups may help determine the potential mechanism underlying CYP2E1 genotypic variations and risk of GDM. The gene discussed is CYP2E1; the disease is gestational diabetes.